Status:
RECRUITING
Bowel Dysfunction and HoLEP Outcomes
Lead Sponsor:
Northwestern University
Conditions:
Urologic Injuries
Eligibility:
MALE
18-89 years
Brief Summary
The objective of this prospective study is to examine the correlation and effects of bowel dysfunction on outcomes for patients undergoing holmium laser enucleation of prostate (HoLEP) for lower urina...
Eligibility Criteria
Inclusion Criteria:
- Males18-89 undergoing HoLEP
- Able to read, understand, and complete patient questionnaires
- Willing to sign the informed consent form
Exclusion Criteria:
- Patients with bowel diversion (colostomy, ileostomy)
- Patients with known neurogenic bowel
- Patients having concurrent ureteroscopy+/-laser lithotripsy, percutaneous nephrolithotomy, or non-urologic surgery at time of HoLEP
- Anticipated need for perineal urethrostomy at time of HoLEP
- Prior pelvic radiation or patients with history of bladder cancer with or without Bacillus Calmette-Guerin (BCG) therapy
- Patients who lack decisional capacity
Key Trial Info
Start Date :
October 5 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2025
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT06688500
Start Date
October 5 2023
End Date
October 31 2025
Last Update
November 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Medicine
Chicago, Illinois, United States, 60611